Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer
To access this article, please choose from the options below
PII: S0960-9776(10)00155-4
doi:10.1016/j.breast.2010.06.005
© 2010 Elsevier Ltd. All rights reserved.
